Drug application
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE, PRIMAQUINE PHOSPHATE)
Drugs@FDA NDA 014860 · SANOFI AVENTIS US
Key facts
| Drug name | ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE |
|---|---|
| Active ingredients | CHLOROQUINE PHOSPHATE, PRIMAQUINE PHOSPHATE |
| Application type | NDA |
| Application number | 014860 |
| Company | SANOFI AVENTIS US |
| Dosage forms | TABLET, ORAL |
| Strength | EQ 300MG BASE;EQ 45MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Dec 9, 1968 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.